GlassScriptPhysician profile
Stefan Lorincz
NPI 1346383643
$3,823.27
in general payments reported to CMS, 2019-2025
13 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $650 · 2020: $669 · 2021: $1,317 · 2022: $553 · 2023: $39.67 · 2024: $487 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $633.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $1,669.86 | 2020-2021 | |
| Organogenesis INC. | $728.34 | 2021-2025 | Puraply Wound Matrix, Puraply |
| Melinta Therapeutics, LLC | $375.00 | 2019 | |
| Smith+Nephew, INC. | $194.36 | 2019-2022 | |
| Arthrex, INC. | $172.80 | 2020 | |
| Innovation Technologies INC | $156.11 | 2024 | Irrisept |
| Allergan, INC. | $150.73 | 2019 | |
| Boston Scientific Corporation | $118.10 | 2022 | |
| Horizon Therapeutics Plc | $103.71 | 2022-2023 | Krystexxa |
| Treace Medical Concepts, INC. | $57.09 | 2022 | |
| Paratek Pharmaceuticals, INC. | $40.83 | 2020 | |
| Stryker Corporation | $29.92 | 2022 | |
| Abbott Laboratories | $26.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stefan Lorincz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.